Mounjaro is the brand name for tirzepatide, a prescription medicine licensed in the United Kingdom as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes mellitus
Major Ingredients Water, Methylpropanediol, Glycerin, Cetyl Ethylhexanoate, Ethylhexyl Stearate, Dipropylene Glycol, Sodium Hyaluronate, Niacinamide, Dexpanthenol (10,000Ppm), Dimethicone, Butylene Glycol, Polysorbate 80, Sorbitan Sesquioleate, Polyacrylamide, Carbomer, Arginine, C13-14 Isoalkane, Laureth-7, Betaine, Trehalose, Glutathione, Alpha-Arbutin (1,000Ppm), Allantoin, Chlorphenesin, Phenoxyethanol, Dipotassium Glycyrrhizate, 1,2-Hexanediol, Anthemis Nobilis Flower Extract, Hamamelis Virginiana (Witch Hazel) Extract, Aloe Barbadensis Leaf Extract, Rosa Centifolia Flower Water, Camellia Sinensis Leaf Extract, Centella Asiatica Extract, Adenosine, Retinol (100Ppm), Disodium Edta, Fragrance, Linalool, Benzyl Salicylate, Coumarin, Hydroxycitronellal, Alpha-Isomethyl Ionone, Limonene This list of ingredients represents all options or variants of this product
Daniel Druckers recent review highlights how GLP-1-based therapies are moving beyond glucose control into cardiovascular, renal, hepatic, and neurologic disease
This section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders
